Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patients

Background Transthoracic device closure of ventricular septal defect (VSD) is widely used in the clinic, especially in China. Changes in inflammatory marker levels after transthoracic device closure of VSD in pediatric patients have not been reported.